Alteri Wealth LLC: SHLD position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Alteri Wealth LLC on SHLD, newest first. How the timeline and the estimate are built.
Alteri Wealth LLC held 12,291 SHLD shares at 2026-06-30 per its 13F-HR filed 2026-07-29.
the latest 13F is the newest step
- period ended2026-06-3013F 12,291 sharesChange vs previous 13F +656 shares
0.2% of the 13F portfolio, value $733,923.
13F-HR 0001765380-26-000232 filed by Alteri Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 11,635 sharesChange vs previous 13F +1,402 shares
0.27% of the 13F portfolio, value $824,256.
13F-HR 0001765380-26-000172 filed by Alteri Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 10,233 sharesChange vs previous 13F +3,879 shares
0.21% of the 13F portfolio, value $662,996.
13F-HR 0001765380-26-000101 filed by Alteri Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 6,354 sharesChange vs previous 13F +1,527 shares
0.15% of the 13F portfolio, value $446,305.
13F-HR 0001765380-25-000456 filed by Alteri Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 4,827 sharesChange vs previous 13F +524 shares
0.11% of the 13F portfolio, value $290,827.
13F-HR 0001765380-25-000322 filed by Alteri Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 4,303 sharesChange vs previous 13F not available
0.09% of the 13F portfolio, value $200,305.
13F-HR 0001765380-25-000184 filed by Alteri Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).